Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tomoharu, Takeoka"'
Autor:
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Takafumi Nakao, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Satoshi Iyama, Junki Inamura, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Shinya Kimura
Publikováno v:
HemaSphere, Vol 7, p e9072115 (2023)
Externí odkaz:
https://doaj.org/article/5d46986c1a534c98a9f192f73aea65a5
Autor:
Fumiya Wada, Junya Kanda, Kimimori Kamijo, Masashi Nishikubo, Satoshi Yoshioka, Takayuki Ishikawa, Yasunori Ueda, Takashi Akasaka, Yasuyuki Arai, Kiyotaka Izumi, Hirokazu Hirata, Takashi Ikeda, Akihito Yonezawa, Naoyuki Anzai, Mitsumasa Watanabe, Kazunori Imada, Kazuhiro Yago, Naoki Tamura, Mitsuru Itoh, Yuki Masuo, Akane Kunitomi, Tomoharu Takeoka, Toshiyuki Kitano, Nobuyoshi Arima, Masakatsu Hishizawa, Kohsuke Asagoe, Tadakazu Kondo, Akifumi Takaori-Kondo
Publikováno v:
Cell Transplantation, Vol 32 (2023)
Haploidentical-related donor transplantation using posttransplant cyclophosphamide (PTCy-haplo) and cord blood transplantation (CBT) are valid alternatives for patients with hematological malignancies when HLA-matched donor transplantation (MDT) is u
Externí odkaz:
https://doaj.org/article/9e9f608734264cc4a084a24e70911b2b
Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan
Autor:
Tomoki Iemura, Tadakazu Kondo, Atsushi Ueda, Takeshi Maeda, Toshio Kitawaki, Yasuyuki Arai, Junya Kanda, Takashi Ikeda, Kazunori Imada, Takayuki Ishikawa, Naoyuki Anzai, Mitsuru Itoh, Tomoharu Takeoka, Takashi Akasaka, Kazuhiro Yago, Akihito Yonezawa, Nobuyoshi Arima, Toshiyuki Kitano, Masaharu Nohgawa, Mitsumasa Watanabe, Toshinori Moriguchi, Kouhei Yamashita, Yasunori Ueda, Kana Matsumoto, Akifumi Takaori-Kondo
Publikováno v:
Annals of Hematology.
Autor:
Hiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, Kensuke Usuki, Hideo Tanaka, Masaya Okada, Shugo Kowata, Kazunori Murai, Asao Hirose, Motohiro Shindo, Takashi Kumagai, Tomoharu Takeoka, Kazuharu Kamachi, Keisuke Kidoguchi, Takafumi Nakao, Takero Shindo, Satoshi Iyama, Junki Inamura, Tsutomu Kobayashi, Eri Kawata, Hiroshi Ohkawara, Takayuki Ikezoe, Atsushi Kawaguchi, Shinya Kimura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::764c8ea9ebed868c1b626453b00f7124
https://doi.org/10.2139/ssrn.4402720
https://doi.org/10.2139/ssrn.4402720
Autor:
Mari Morita-Fujita, Takero Shindo, Tomoki Iemura, Yasuyuki Arai, Junya Kanda, Kazuya Okada, Yasunori Ueda, Onda Yoshiyuki, Naoyuki Anzai, Takuto Mori, Takayuki Ishikawa, Yasuyuki Otsuka, Akihito Yonezawa, Naoki Yuhi, Kazunori Imada, Akifumi Oba, Mitsuru Itoh, Yoshio Okamoto, Toshiyuki Kitano, Takashi Ikeda, Shinichi Kotani, Takashi Akasaka, Kazuhiro Yago, Mitsumasa Watanabe, Masaharu Nohgawa, Masaaki Tsuji, Tomoharu Takeoka, Ryusuke Yamamoto, Nobuyoshi Arima, Noriyoshi Yoshinaga, Masakatsu Hishizawa, Kouhei Yamashita, Tadakazu Kondo, Akifumi Takaori-Kondo
Publikováno v:
Transplantation and Cellular Therapy. 29:347.e1-347.e11
Autor:
Masaaki Tsuji, Tatsuki Uchiyama, Chisaki Mizumoto, Tomoharu Takeoka, Kenjiro Tomo, Tatsuharu Ohno
Publikováno v:
Case Reports in Hematology, Vol 2017 (2017)
Myeloid blast crisis of chronic myeloid leukemia (CML-MBC) is rarely seen at presentation and has a poor prognosis. There is no standard therapy for CML-MBC. It is often difficult to distinguish CML-MBC from acute myeloid leukemia expressing the Phil
Externí odkaz:
https://doaj.org/article/23ebbc1230a849bc923bc6f422487287
Autor:
Masakatsu Hishizawa, Yasunori Ueda, Toshiyuki Kitano, Nobuyoshi Arima, Naoyuki Anzai, Mitsuru Itoh, Junya Kanda, Mizuki Watanabe, Akihito Yonezawa, Kazunori Imada, Mitsumasa Watanabe, Kazuhiro Yago, Momoko Nishikori, Masaharu Nohgawa, Toshinori Moriguchi, Tomoharu Takeoka, Takashi Akasaka, Tadakazu Kondo, Akifumi Takaori-Kondo, Takayuki Ishikawa, Yasuyuki Arai
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2346-2358
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the key strategy to cure patients with mature T and natural killer (NK) cell lymphomas/leukemia, especially those with relapsed/refractory diseases, there is no consensus stra
Autor:
Jun Imagawa, Yoshiaki Chinen, Toru Kiguchi, Chisaki Mizumoto, Katsumichi Fujimaki, Toshihiro Fukushima, Masayuki Mita, Kazunori Murai, Satoshi Wakita, Takayuki Ikezoe, Satoshi Kimura, Chikashi Yoshida, Takaaki Ono, Takeshi Kondo, Atsushi Kawaguchi, Junichi Sakamoto, Ayako Takamori, Jun Aoki, Katsuhiro Io, Kaori Karimata, Yasufumi Matsuda, Kaichi Nishiwaki, Kensuke Usuki, Hirohiko Shibayama, Joji Shimono, Takashi Kumagai, Tomoharu Takeoka, Junya Kuroda, Shinya Kimura, Masatomo Miura, Kensuke Nakao, Yousuke Minami, Nobuhiko Uoshima, Hiroshi Ureshino, Koiti Inokuchi, Hideo Tanaka
Publikováno v:
The Lancet. Haematology. 8(12)
Summary Background BCR-ABL1 tyrosine kinase inhibitors (TKIs) are commonly initiated in older patients with chronic myeloid leukaemia in the chronic phase at standard doses. However, because of their safety profile in this population, appropriate the
Autor:
Nobuhiko Uoshima, Masayuki Mita, Chisaki Mizumoto, Hiroshi Ureshino, Satoshi Wakita, Hirohiko Shibayama, Koiti Inokuchi, Satoshi Kimura, Kaori Karimata, Kensuke Nakao, Joji Shimono, Toru Kiguchi, Kaichi Nishiwaki, Hideo Tanaka, Katsumichi Fujimaki, Takayuki Ikezoe, Katsuhiro Io, Takashi Kumagai, Toshihiro Fukushima, Atsushi Kawaguchi, Yoshiaki Chinen, Yasufumi Matsuda, Ayako Takamori, Kazunori Murai, Jun Aoki, Yosuke Minami, Takaaki Ono, Takeshi Kondo, Chikashi Yoshida, Junya Kuroda, Junichi Sakamoto, Tomoharu Takeoka, Shinya Kimura, Masatomo Miura, Kensuke Usuki, Jun Imagawa
Publikováno v:
Blood. 138:3601-3601
Introduction: Tyrosine kinase inhibitors (TKIs) dramatically improved the prognosis of chronic myelogenous leukemia (CML), as nearly half of CML patients presenting with a deep molecular response (DMR) over several years could achieve treatment-free
Autor:
Naoyuki Anzai, Satoshi Yoshioka, Fumiya Wada, Tomoharu Takeoka, Toshiyuki Kitano, Kosuke Asagoe, Nobuyoshi Arima, Mitsumasa Watanabe, Masaharu Nohgawa, Junya Kanda, Akihito Yonezawa, Akifumi Takaori-Kondo, Yasuyuki Arai, Hirokazu Hirata, Kazuhiro Yago, Tadakazu Kondo, Kazunori Imada, Mitsuru Itoh, Takashi Ikeda, Takashi Akasaka, Takayuki Ishikawa, Masakatsu Hishizawa, Yasunori Ueda
Publikováno v:
Blood. 138:2927-2927
Introduction: Unrelated cord blood (UCB) and haploidentical related donor transplantation using post-transplant cyclophosphamide (PTCy-haplo) have become alternative options to treat patients with hematological malignancies without a human leukocyte